Stock-Based Compensation - Schedule of Analysis of Unvested Restricted Stock (Details) - shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Beginning Balance (in shares)	446,645	398,535	342,966
Grants (in shares)	210,040	194,864	166,202
Additional performance shares	84,712	(28,857)	(16,102)
Restriction lapses (in shares)	(155,877)	(100,887)	(87,031)
Forfeitures (in shares)	(16,008)	(17,010)	(7,500)
Ending Balance (in shares)	569,512	446,645	398,535
Executive Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Beginning Balance (in shares)	354,080	398,535	342,388
Grants (in shares)	96,800	81,300	146,500
Additional performance shares	84,712	(28,857)	(16,102)
Restriction lapses (in shares)	(143,211)	(84,298)	(66,751)
Forfeitures (in shares)	(6,000)	(12,600)	(7,500)
Ending Balance (in shares)	386,381	354,080	398,535
Directors Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Beginning Balance (in shares)	0	0	289
Grants (in shares)	7,375	7,110	10,746
Additional performance shares	0	0	0
Restriction lapses (in shares)	(7,375)	(7,110)	(11,035)
Forfeitures (in shares)	0	0	0
Ending Balance (in shares)	0	0	0
Directors Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Beginning Balance (in shares)	0	0	289
Grants (in shares)	4,854	9,479	8,956
Additional performance shares	0	0	0
Restriction lapses (in shares)	(4,854)	(9,479)	(9,245)
Forfeitures (in shares)	0	0	0
Ending Balance (in shares)	0	0	0
Employees Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Beginning Balance (in shares)	92,565	0	0
Grants (in shares)	101,011	96,975	0
Additional performance shares	0	0	0
Restriction lapses (in shares)	(437)	0	0
Forfeitures (in shares)	(10,008)	(4,410)	0
Ending Balance (in shares)	183,131	92,565	0